S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

EVOK Evoke Pharma Inc

0.475

0.044 (10.21%)

01 Jun 2024 - Closed

Delayed by 15 minutes

Form ARS/A - Annual Report to Security Holders: [Amend]

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Evoke Pharma Charts.

Evoke Pharma (NASDAQ:EVOK)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Evoke Pharma Charts.

Evoke Pharma Inc News

Form 3 - Initial statement of beneficial ownership of securities
Friday 31 May 2024 (1 day ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 May 2024 (1 week ago) • Edgar (US Regulatory)

Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
Friday 17 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Evoke Pharma Reports First Quarter 2024 Financial Results
Wednesday 15 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 15 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Wednesday 15 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 15 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications
Wednesday 17 April 2024 (1 month ago) • GlobeNewswire Inc.

Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive Officer
Friday 22 March 2024 (2 months ago) • GlobeNewswire Inc.

More Evoke Pharma Inc News Articles

NLBNPIT1VKU4 20351221 21...

Sensio Technologies (CE)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions